Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Uterine Leiomyoma (Uterine Fibroids) - Overview
Uterine Leiomyoma (Uterine Fibroids) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Uterine Leiomyoma (Uterine Fibroids) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Uterine Leiomyoma (Uterine Fibroids) - Companies Involved in Therapeutics Development
AbbVie Inc
Addex Therapeutics Ltd
Auritec Pharmaceuticals Inc
Bayer AG
BioSpecifics Technologies Corp
GeneScience Pharmaceuticals Co Ltd
Immunitor Inc
Kissei Pharmaceutical Co Ltd
Livzon Pharmaceutical Group Co Ltd
Luye Pharma Group Ltd
Richter Gedeon Nyrt
Takeda Pharmaceutical Co Ltd
Uterine Leiomyoma (Uterine Fibroids) - Drug Profiles
collagese clostridium histolyticum - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CTX-30916 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Drug to Agonize Progesterone Receptor for Uterine Fibroids - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
EC-313 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
elagolix sodium - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
leuprolide acetate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
leuprolide acetate SR - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
linzagolix choline - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NCE-403 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
relugolix - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Antagonize FSH Receptor and LH Receptor for Women’s Health - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
triptorelin acetate ER - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
triptorelin acetate SR - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ulipristal acetate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
V3-Myoma - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
vilaprisan - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Uterine Leiomyoma (Uterine Fibroids) - Dormant Projects
Uterine Leiomyoma (Uterine Fibroids) - Discontinued Products
Uterine Leiomyoma (Uterine Fibroids) - Product Development Milestones
Featured News & Press Releases
Appendix



List of Figures


Number of Products under Development for Uterine Leiomyoma (Uterine Fibroids), H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products by Targets, H2 2019
Number of Products by Stage and Targets, H2 2019
Number of Products by Mechanism of Actions, H2 2019
Number of Products by Stage and Mechanism of Actions, H2 2019
Number of Products by Routes of Administration, H2 2019
Number of Products by Stage and Routes of Administration, H2 2019
Number of Products by Molecule Types, H2 2019
Number of Products by Stage and Molecule Types, H2 2019


List of Tables


Number of Products under Development for Uterine Leiomyoma (Uterine Fibroids), H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Products under Development by Companies, H2 2019
Products under Development by Universities/Institutes, H2 2019
Number of Products by Stage and Target, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Uterine Leiomyoma (Uterine Fibroids) - Pipeline by AbbVie Inc, H2 2019
Uterine Leiomyoma (Uterine Fibroids) - Pipeline by Addex Therapeutics Ltd, H2 2019
Uterine Leiomyoma (Uterine Fibroids) - Pipeline by Auritec Pharmaceuticals Inc, H2 2019
Uterine Leiomyoma (Uterine Fibroids) - Pipeline by Bayer AG, H2 2019
Uterine Leiomyoma (Uterine Fibroids) - Pipeline by BioSpecifics Technologies Corp, H2 2019
Uterine Leiomyoma (Uterine Fibroids) - Pipeline by GeneScience Pharmaceuticals Co Ltd, H2 2019
Uterine Leiomyoma (Uterine Fibroids) - Pipeline by Immunitor Inc, H2 2019
Uterine Leiomyoma (Uterine Fibroids) - Pipeline by Kissei Pharmaceutical Co Ltd, H2 2019
Uterine Leiomyoma (Uterine Fibroids) - Pipeline by Livzon Pharmaceutical Group Co Ltd, H2 2019
Uterine Leiomyoma (Uterine Fibroids) - Pipeline by Luye Pharma Group Ltd, H2 2019
Uterine Leiomyoma (Uterine Fibroids) - Pipeline by Richter Gedeon Nyrt, H2 2019
Uterine Leiomyoma (Uterine Fibroids) - Pipeline by Takeda Pharmaceutical Co Ltd, H2 2019
Uterine Leiomyoma (Uterine Fibroids) - Dormant Projects, H2 2019
Uterine Leiomyoma (Uterine Fibroids) - Dormant Projects, H2 2019 (Contd..1), H2 2019
Uterine Leiomyoma (Uterine Fibroids) - Discontinued Products, H2 2019